Migraine can take its toll on the whole family. Listen to Ethan's experience with migraine, and how it has affected him and the lives around him.
Biohaven Pharmaceuticals is studying an investigational drug to potentially treat migraines in children and teens. If your child is between 6 and 17 years of age and has at least a 6-month history of migraine, they may qualify. Learn more about our pediatric migraine study.